Gerresheimer partners with RxCap to offer connected adherence solutions  Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S. Adherence solutions enables pharmacies to offer remote therapeutic monitoring Digital therapy support leads to improved health outcomes Düsseldorf/Berlin, Ohio, USA, April 29, 2 [ … ]

Gerresheimer partners with RxCap to offer connected adherence solutions  Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S. Adherence solutions enables pharmacies to offer remote therapeutic monitoring Digital therapy support leads to improved health outcomes Düsseldorf/Berlin, Ohio, USA, April 29, 2 [ … ]

Gerresheimer makes solid start to the financial year 2024 Organic growth: Revenues +2.8%, adjusted EBITDA +5.9%  Capacity expansion in the Americas, Europe and Asia progresses according to plan Guidance confirmed Düsseldorf, April 11, 2024 Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and [ … ]

Gerresheimer decisively continues on profitable growth course in financial year 2023 Organic revenue growth in 2023: +10.4% Organic adjusted EBITDA growth in 2023: +17.5% Favorable product mix boosts profitability High order backlog and global capacity expansion secure profitable growth for the years ahead   Düsseldorf, February 22, 2024. Gerr [ … ]

Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy  Subcutaneous administration of oncology drugs with digital therapy support Integrating Gx SensAir drug delivery device with Aptar's Digital Health platform Solution aims to improve the patient experience and quality of life of cancer patients   D [ … ]